Ten-Year Trends in Sleep-Disordered Breathing After Ischemic Stroke: 2010 to 2019 Data From the BASIC Project.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
15 02 2022
Historique:
pubmed: 15 2 2022
medline: 9 4 2022
entrez: 14 2 2022
Statut: ppublish

Résumé

Background Despite good evidence that the prevalence of sleep-disordered breathing (SDB) is increasing in the general population, no data are available about trends in poststroke SDB. We therefore sought to assess changes in poststroke SDB over a 10-year period (2010-2019). Methods and Results Participants in the BASIC (Brain Attack Surveillance in Corpus Christi) project were offered a home sleep apnea test to assess for SDB after stroke. SDB assessment procedures remained unchanged throughout the study period. Respiratory event index was calculated as the sum of apneas and hypopneas per hour of recording. SDB was defined as respiratory event index ≥10/h for optimal sensitivity and specificity of the home sleep apnea test device compared with in-laboratory polysomnography. Regression models were used to test associations between SDB prevalence and severity and time, with adjustment for multiple potential confounders. Among the 1215 participants who completed objective sleep apnea testing, the prevalence of SDB grew from 61% in the first year of the study to 76% in the last, with 1.1 times higher odds each year (95% CI, 1.07-1.19), after adjustment. A linear association was identified between time and respiratory event index (average annual respiratory event index increase of 0.56/h; 95% CI, 0.20/h-0.91/h), after adjustment. There was no difference in time trends by sex or ethnicity. Conclusions The prevalence and severity of SDB after ischemic stroke has increased over the past 10 years in this population-based cohort. These data highlight the need to determine whether SDB treatment improves stroke outcomes.

Identifiants

pubmed: 35156416
doi: 10.1161/JAHA.121.024169
pmc: PMC9245813
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e024169

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS038916
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG000040
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123379
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126700
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL098065
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS070941
Pays : United States

Références

Sleep Med Rev. 2017 Dec;36:116-124
pubmed: 28599983
Neurology. 2018 Apr 3;90(14):e1222-e1230
pubmed: 29523641
Sleep Med. 2021 Jan;77:304-306
pubmed: 32948418
Sleep Breath. 2014 Mar;18(1):165-8
pubmed: 23771345
Curr Opin Neurol. 2020 Feb;33(1):4-9
pubmed: 31809332
Ann Intern Med. 1999 Oct 5;131(7):485-91
pubmed: 10507956
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Neurology. 2019 Feb 12;92(7):e648-e654
pubmed: 30635478
Ann Neurol. 2019 Aug;86(2):241-250
pubmed: 31155749
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
Ann Neurol. 2013 Dec;74(6):778-85
pubmed: 23868398
Am J Epidemiol. 2013 May 1;177(9):1006-14
pubmed: 23589584

Auteurs

Sonja G Schütz (SG)

Department of Neurology University of Michigan Ann Arbor MI.

Lynda D Lisabeth (LD)

Department of Epidemiology University of Michigan Ann Arbor MI.

River Gibbs (R)

Department of Epidemiology University of Michigan Ann Arbor MI.

Xu Shi (X)

Department of Biostatistics University of Michigan Ann Arbor MI.

Ronald D Chervin (RD)

Department of Neurology University of Michigan Ann Arbor MI.

Madeline Kwicklis (M)

Department of Epidemiology University of Michigan Ann Arbor MI.

Erin Case (E)

Department of Epidemiology University of Michigan Ann Arbor MI.

Devin L Brown (DL)

Department of Neurology University of Michigan Ann Arbor MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH